Observed Apixaban Anti-Xa Levels in Obese Patients.

Harkness, Weston; Pipitone, Olivia; Joss, Jacqueline; Schiedler, Michael; Shagavah, Santon; Moore, Ryan; Hsing, Jeff

Harkness, Weston; Pipitone, Olivia; Joss, Jacqueline; Schiedler, Michael; Shagavah, Santon; Moore, Ryan; Hsing, Jeff.

Afiliação

Harkness W; Cardiology, Samaritan Health Services, Corvallis, OR, USA.
Pipitone O; Samaritan Health Outcomes Research & Evaluation, Samaritan Health Services, Corvallis, OR, USA.
Joss J; Ambulatory Pharmacy, Samaritan Health Services, Corvallis, OR, USA.
Schiedler M; Cardiology, Salem Health Medical Group, Salem, OR, USA.
Shagavah S; Multnomah County Health Department, Portland, OR, USA.
Moore R; Inpatient Pharmacy, Samaritan Health Services, Corvallis, OR, USA.
Hsing J; Cardiology, Samaritan Health Services, Corvallis, OR, USA.

Ann Pharmacother ; : 10600280221077158, 2022 Feb 15.

Article em En | MEDLINE | ID: mdl-35168381

Palavras-chave

anti-Xa assay; apixaban; direct oral anticoagulant; obesity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google